Tyler Hitchman, PhD

Postdoctoral Research Fellow at Memorial Sloan Kettering in New York, NY

Tyler Hitchman, PhD

Postdoctoral Research Fellow at Memorial Sloan Kettering in New York, NY

Share
Print
Share
Print
Tyler Hitchman

Dissertation

Interrogating and Targeting Essential Signaling Pathways in Uveal Melanoma. (2021)

Start Year

2016

End Year

2021

Education

BS, Clarkson University

I am interested in cancer biology, melanocyte biology, tumorigenesis, animal models of disease, and signaling transduction. My graduate work focuses on understanding essential signaling pathways in uveal melanoma (UVM). UVMs harbor activating mutations found exclusively in the heterotrimeric Gq signaling pathway. Recent studies have revealed the underlying genetic landscape of uveal melanoma but have not resulted in any therapeutic options to effectively treat this disease. My thesis project will explore Gq signaling in UVM tumorigenesis and identify targets with therapeutic potential in UVM.

I chose to pursue my graduate studies at Gerstner Sloan Kettering because of its renowned cancer research program. Students benefit from the small class size, which allows for a more intimate community among peers, faculty, and the dean’s office.

Fellowships

  • Ruth L. Kirschstein Predoctoral Individual National Research Service Award (NIH F31) (2019-2022)

View a full listing of Tyler Hitchman’s journal articles.